Off-label direct oral anticoagulant (DOAC) dosing is very common and is linked to serious adverse events. MAQI2 is proud to be selected as a Michigan Medicine Quality Month Exemplar Finalist in recognition of our efforts to reduce off-label DOAC dosing. Thanks to all of our sites for their commitment to improve patient safety!
You can download the poster here.
- Log in to post comments